	Survival Outcomes of Post-Induction Treatment Strategies in Patients With Partial Response Hypopharyngeal Squamous Cell Carcinoma: A Propensity Score-Weighted Analysis. Cancer Med Lau HC, Huang H, Li J, Wang T, Mao X, Wang Z, Hsueh CY, Zhang M, Xu C. PMID: 42885440 [PubMed - indexed for MEDLINE]
	Advances in neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma (Review). Oncol Rep You H, Qin X, Fu S. PMID: 42885303 [PubMed - indexed for MEDLINE]
	Folic Acid Oversupplementation Alters Global DNA Methylation and Circadian Clock Gene Expression in FaDu Head and Neck Squamous Cell Carcinoma Cells: An Exploratory Study. Nutrients Faramarzi Garous N, Lobanova L, Papagerakis S, Lieffers JRL, Said RS, Papagerakis P. PMID: 42884632 [PubMed - indexed for MEDLINE]
	Immune Checkpoint Inhibitor Data in Metastatic Melanoma with Pre-Existing Autoimmune Disease: A Real World Experience. Int J Mol Sci Vitale MG, Mallardo D, Sparano F, Festino L, Vanella V, Trojaniello C, Ottaviano M, Cioli E, Mallardo M, Facchini BA, Simeone E, Ascierto PA. PMID: 42884075 [PubMed - indexed for MEDLINE]
	Recent Advances in Nanomedicine-Enhanced Photodynamic Therapy in Cutaneous Oncology: Melanoma-Dominant Evidence for Immunogenic Cell Death and Photoimmunotherapy. Int J Mol Sci Bartusik-Aebisher D, Wilk I, Aebisher D. PMID: 42883966 [PubMed - indexed for MEDLINE]
	Advances in Treatment of Refractory Advanced and Recurrent Cervical Adenocarcinoma: Molecular Heterogeneity and Differences from Squamous Cell Carcinoma. Int J Mol Sci Taira Y, Kudaka W, Shimoji Y, Nakamoto T, Arakaki Y, Oyama T, Yoshida A, Watanabe T, Akamine H, Komesu I, Sekine M. PMID: 42883892 [PubMed - indexed for MEDLINE]
	PD-L1 in Merkel Cell Carcinoma: From Tumor Microenvironment to Pathological Interpretation. Int J Mol Sci Pepe L, Fiorentino V, Della Mura M, Rizzo A, Santarpia M, Ieni A, Cazzato G, Lentini M. PMID: 42883708 [PubMed - indexed for MEDLINE]
	pTINCR Expression Is Associated with Tumor Aggressiveness but Does Not Independently Predict Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma. Int J Mol Sci Santos-Juanes R, Santos-Juanes J, Blanco-Agudín N, Merayo-Lloves J, Vivanco B, García-Pedrero JM, Rodrigo JP, Fernández-Vega I, Galache C. PMID: 42883691 [PubMed - indexed for MEDLINE]
	Advancing Electrochemotherapy in Melanoma and Non-Melanoma Skin Cancer: From Clinical Practice to Emerging Frontiers. Int J Mol Sci Marrapodi R, Presaghi A, Migliano E, Bellei B. PMID: 42883690 [PubMed - indexed for MEDLINE]
	Determination of the Content of Isoquinoline Alkaloids in Selected Plant Extracts and Study of Their Cholinesterase-Inhibiting Activity and Cytotoxicity Against Human Melanoma Cells Using In Vitro and In Silico Methods. Molecules Tuzimski T, Petruczynik A, Sugajski M, Plech T, Kapro, Wróblewski K, Buszewski B. PMID: 42883309 [PubMed - indexed for MEDLINE]
	Lymphatic Mapping to the Inguinal Region in Patients with Lower Extremity Melanoma Undergoing Radical Inguinal Lymph Node Dissection: A Retrospective Cohort Study. Cancers (Basel) Tan Z, Sun Y, Zhang Y, Fan Z, Bai C, Li S, Gao T, Zhang L, Xue R, Wang X, Liu M, Wang H, Liu J. PMID: 42882878 [PubMed]
	Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial. Cancers (Basel) Borgers JSW, Wu CC, Medina TM, Muckle CM, Katsnelson EN, Whitty PA, Mantle L, Patel SP, Gao D, Jordan KR, Robinson WA, Tobin RP, McCarter MD, Couts KL. PMID: 42882866 [PubMed]
	Dermatologic Toxicities Associated with Tebentafusp for Uveal Melanoma: A Review of Clinical Trials and Real-World Evidence. Cancers (Basel) Koumprentziotis IA, Bakella A, Nikolaou V, Koumaki D. PMID: 42882766 [PubMed]
	Salivary miR-21 and miR-31 in Oral Squamous Cell Carcinoma: Molecular Pathogenesis, Diagnostic Significance, and Translation to Isothermal RPA. Cells Ranbhise JS, Singh MK, Yun HR, Han S, Kim SS, Kang I. PMID: 42882497 [PubMed - indexed for MEDLINE]
	Redox Storm in the Tumor Microenvironment (Î¤ÎœÎ•): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface. Cells Karakousis VA, Sioga A, Vizirianakis IS, Kesisoglou I, Kosmidis CS, Pavlidis L, Papamitsou T. PMID: 42882458 [PubMed - indexed for MEDLINE]
	Depression and Anxiety in Melanoma Patients and Their Relationships with Dermatology-Related Quality of Life: A Prospective Observational Cross-Sectional Study. J Clin Med Hrynczyszyn M, , Piesch P, Kr, Adamska H, Bu, Szepietowska M, Krajewski PK, Pacan P, Kami, Zi, Matusiak , Szepietowski JC. PMID: 42881985 [PubMed]
	Plasma autoantibody profiling via PhIP-seq and machine learning for diagnosis of esophageal squamous cell carcinoma. Nat Commun Jin MJ, Xu YW, He XX, Ma ML, Wu WZ, Zhang JF, Pan DY, Chen SX, Wang G, Huang QF, Chen SZ, Huang HC, Peng YH, Tao SC, Li Y, Li EM, Xu LY. PMID: 42881190 [PubMed - indexed for MEDLINE]
	Study of lung structure as a potential pre-metastatic niche in mice with B16 melanoma. Tissue Cell Shatruk A, Bgatova N, Taskaeva I. PMID: 42880136 [PubMed - as supplied by publisher]
	Real-time assessment of mitotic rate in malignant melanoma by ex vivo confocal microscopy. Clin Exp Dermatol Hartmann D, Wex K, Braun A, Swarlik A, Buttgereit L, Stärr L, Ohlmann A, Sattler EC, Deußing M. PMID: 42879802 [PubMed - as supplied by publisher]
	Lipid droplet organized metabolic vulnerabilities in melanoma: from the MITF low state to ferroptosis sensitization. Front Mol Biosci Chen M, Wu Y, Zhao M. PMID: 42877483 [PubMed]

Articles 1 - 20 / 145284

Page 1 of 7265



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy